Proinflammatory cytokines cause down-regulation of renal chloride entry pathways during sepsis

Critical Care Medicine

Volumn 35, Issue 9, 2007, Pages 2110-2119

  Schmidt, Christoph ^a   Höcherl, Klaus ^a   Schweda, Frank ^a   Bucher, Michael ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Acute renal failure; Chloride transporters channels; Cytokines; Glucocorticoids; Ischemia; Lipopolysaccharide

Indexed keywords

CHLORIDE; CHLORIDE CHANNEL; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITROPRUSSIDE SODIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CLAMP; ARTICLE; BLOOD PRESSURE; C57BL 6 MOUSE; CHLORIDE TRANSPORT; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HYPOTENSION; INFLAMMATION; KIDNEY DISEASE; KIDNEY ISCHEMIA; KIDNEY TUBULE ABSORPTION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL ARTERY; SEPSIS; SINGLE DRUG DOSE; TUBULAR DYSFUNCTION;

ANIMALS; CHLORIDES; DOWN-REGULATION; GLUCOCORTICOIDS; INTERFERON TYPE II; INTERLEUKIN-1BETA; INTERLEUKIN-6; KIDNEY; MALE; MICE; MICE, INBRED C57BL; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN-1 TYPE I; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548260378     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ccm.0000281447.22966.8b     Document Type: Article

References (60)

1. Kere J: Kidney kinetics and chloride ion pumps. Nat Genet 1999; 21:67-68
2. Matsumura Y, Uchida S, Kondo Y, et al: Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. Nat Genet 1999; 21:95-98
3. Simon DB, Bindra RS, Mansfield TA, et al: Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 1997; 17:171-178
4. Simon DB, Karet FE, Hamdan JM, et al: Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 1996; 13:183-188
5. Obermuller N, Bernstein P, Velazquez H, et al: Expression of the thiazide-sensitive Na-Cl cotransporter in rat and human kidney. Am J Physiol 1995; 269:F900-F910
6. Plotkin MD, Kaplan MR, Verlander JW, et al: Localization of the thiazide sensitive Na-Cl cotransporter, rTSC1, in the rat kidney. Kidney Int 1996; 50:174-183
7. Yang T, Huang YG, Singh I, et al: Localization of bumetanide- and thiazide-sensitive Na-K-Cl cotransporters along the rat nephron. Am J Physiol 1996; 271:F931-F939
8. Adachi S, Uchida S, Ito H, et al: Two isoforms of a chloride channel predominantly expressed in thick ascending limb of Henle's loop and collecting ducts of rat kidney. J Biol Chem 1994; 269:17677-17683
9. Vandewalle A, Cluzeaud F, Bens M, et al: Localization and induction by dehydration of ClC-K chloride channels in the rat kidney. Am J Physiol 1997; 272:F678-F688
10. Yoshikawa M, Uchida S, Yamauchi A, et al: Localization of rat CLC-K2 chloride channel mRNA in the kidney. Am J Physiol 1999; 276:F552-F558
11. + secretion. Nature 2001; 414:558-561
12. Scholl U, Hebeisen S, Janssen AG, et al: Barttin modulates trafficking and function of ClC-K channels. Proc Nat Acad Sci U S A 2006; 103:11411-11416
13. Waldegger S, Jeck N, Barth P, et al: Barttin increases surface expression and changes current properties of ClC-K channels. Pflugers Arch 2002; 444:411-418
14. Wolf K, Castrop H, Riegger GA, et al: Differential gene regulation of renal salt entry pathways by salt load in the distal nephron of the rat. Pflugers Arch 2001; 442:498-504
15. Kohda Y, Ding W, Phan E, et al: Localization of the ROMK potassium channel to the apical membrane of distal nephron in rat kidney. Kidney Int 1998; 54:1214-1223
16. Xu JZ, Hall AE, Peterson LN, et al: Localization of the ROMK protein on apical membranes of rat kidney nephron segments. Am J Physiol 1997; 273:F739-F748
17. Grinevich V, Knepper MA, Verbalis J, et al: Acute endotoxemia in rats induces downregulation of V2 vasopressin receptors and aquaporin-2 content in the kidney medulla. Kidney Int 2004; 65:54-62
18. Schmidt C, Hocherl K, Bucher M: Regulation of renal glucose transporters during severe inflammation. Am J Physiol Renal Physiol 2007; 292:F804-F811
19. Brivet FG, Kleinknecht DJ, Loirat P, et al: Acute renal failure in intensive care units: Causes, outcome, and prognostic factors of hospital mortality. A prospective, multicenter study: French Study Group on Acute Renal Failure. Crit Care Med 1996; 24:192-198
20. Jorres A: Acute renal failure: Extracorporeal treatment strategies. Minerva Med 2002; 93:329-324
21. Liano F, Junco E, Pascual J, et al: The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings: The Madrid Acute Renal Failure Study Group. Kidney Int Suppl 1998; 66:S16-S24
22. Silvester W, Bellomo R, Cole L: Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 2001; 29:1910-1915
23. Uchino S, Doig GS, Bellomo R, et al: Diuretics and mortality in acute renal failure. Crit Care Med 2004; 32:1669-1677
24. Rangel-Frausto MS, Pittet D, Costigan M, et al: The natural history of the systemic inflammatory response syndrome (SIRS): A prospective study. JAMA 1995; 273:117-123
25. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality: A cohort analysis. JAMA 1996; 275:1489-1494
26. Chew SL, Lins RL, Daelemans R, et al: Outcome in acute renal failure. Nephrol Dial Transplant 1993; 8:101-107
27. Nash K, Hafeez A, Hou S: Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39:930-936
28. Bucher M, Hobbhahn J, Kurtz A: Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis. Crit Care Med 2001; 29:1750-1755
29. Bucher M, Hobbhahn J, Taeger K, et al: Cytokine-mediated downregulation of vasopressin V(1A) receptors during acute endotoxemia in rats. Am J Physiol Regul Integr Comp Physiol 2002; 282:R979-R984
30. Bucher M, Ittner KP, Hobbhahn J, et al: Downregulation of angiotensin II type 1 receptors during sepsis. Hypertension 2001; 38:177-182
31. Bucher M, Kees F, Taeger K, et al: Cytokines down-regulate alpha1-adrenergic receptor expression during endotoxemia. Crit Care Med 2003; 31:566-571
32. Briegel J, Jochum M, Gippner-Steppert C, et al: Immunomodulation in septic shock: Hydrocortisone differentially regulates cytokine responses. J Am Soc Nephrol 2001; 12(Suppl 17):S70-S74
33. Keh D, Boehnke T, Weber-Cartens S, et al: Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: A double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003; 167:512-520
34. Kiku Y, Matsuzawa H, Ohtsuka H, et al: Effects of chlorpromazine, pentoxifylline and dexamethasone on mRNA expression of lipopolysaccharide- induced inflammatory cytokines in bovine peripheral blood mononuclear cells. J Vet Med Sci 2002; 64:723-726
35. Knotek M, Rogachev B, Wang W, et al: Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int 2001; 59:2243-2249
36. Wang W, Jittikanont S, Falk SA, et al: Interaction among nitric oxide, reactive oxygen species, and antioxidants during endotoxemia-related acute renal failure. Am J Physiol Renal Physiol 2003; 284:F532-F537
37. Wang W, Zolty E, Falk S, et al: Pentoxifylline protects against endotoxin-induced acute renal failure in mice. Am J Physiol Renal Physiol 2006; 291:F1090-F1095
38. Schmidt C, Hocherl K, Bucher M: Regulation of renal glucose transporters during severe inflammation. Am J Physiol Renal Physiol 2007; 292:F804-F811
39. Nin N, Penuelas O, de Paula M, et al: Ventilation-induced lung injury in rats is associated with organ injury and systemic inflammation that is attenuated by dexamethasone. Crit Care Med 2006; 34:1093-1098
40. Van Molle W, Hochepied T, Brouckaert P, et al: The major acute-phase protein, serum amyloid P component, in mice is not involved in endogenous resistance against tumor necrosis factor alpha-induced lethal hepatitis, shock, and skin necrosis. Infect Immun 2000; 68:5026-5029
41. Mann B, Hartner A, Jensen BL, et al: Acute upregulation of COX-2 by renal artery stenosis. Am J Physiol Renal Physiol 2001; 280:F119-F125
42. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328:1471-1477
43. Camussi G, Ronco C, Montrucchio G, et al: Role of soluble mediators in sepsis and renal failure. Kidney Int Suppl 1998; 66:S38-S42
44. Lugon JR, Boim MA, Ramos OL, et al: Renal function and glomerular hemodynamics in male endotoxemic rats. Kidney Int 1989; 36:570-575
45. Parker SJ, Watkins PE: Experimental models of gram-negative sepsis. Br J Surg 2001; 88:22-30
46. Jonassen TE, Graebe M, Promeneur D, et al: Lipopolysaccharide-induced acute renal failure in conscious rats: Effects of specific phosphodiesterase type 3 and 4 inhibition. J Pharmacol Exp Ther 2002; 303:364-374
47. Schramm L, Weierich T, Heldbreder E, et al: Endotoxin-induced acute renal failure in rats: Effects of L-arginine and nitric oxide synthase inhibition on renal function. J Nephrol 2005; 18:374-381
48. Lorenz JN, Baird NR, Judd LM, et al: Impaired renal NaCl absorption in mice lacking the ROMK potassium channel, a model for type II Bartter's syndrome. J Biol Chem 2002; 277:37871-37880
49. Abraham E: Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med 1999; 25:556-566
50. Fisher CJ Jr, Agosti JM, Opal SM, et al: Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein: The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 1996; 334:1697-1702
51. Opal SM, Fisher CJ Jr, Dhainaut JF, et al: Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med 1997; 25:1115-1124
52. Millar CG, Thiemermann C: Carboxy-PTIO, a scavenger of nitric oxide, selectively inhibits the increase in medullary perfusion and improves renal function in endotoxemia. Shock 2002; 18:64-68
53. Beaumont K, Vaughn DA, Casto R, et al: Thiazide diuretic receptors in spontaneously hypertensive rats and 2-kidney 1-clip hypertensive rats. Clin Exp Hypertens A 1990; 12:215-226
54. + exchanger isoform NHE3 in proximal tubules induced by acute and chronic hypertension. Am J Physiol 1998; 275:F565-F575
55. Zager RA, Johnson AC, Lund S, et al: Acute renal failure: Determinants and characteristics of the injury-induced hyperinflammatory response. Am J Physiol Renal Physiol 2006; 291:F546-F556
56. Zager RA, Johnson A, Anderson K, et al: Cholesterol ester accumulation: An immediate consequence of acute in vivo ischemic renal injury. Kidney Int 2001; 59:1750-1761
57. Annane D, Bellissant E, Bollaert PE, et al: Corticosteroids for treating severe sepsis and septic shock. Cochrane Database Syst Rev 2004; 1:CD002243
58. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
59. Briegel J, Forst H, Haller M, et al: Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27:723-732
60. Kilger E, Weis F, Briegel J, et al: Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 2003; 31:1068-1074